From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision Medicine-Reference-Cited by-同舟云学术

From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision Medicine

Published:2020-02-11 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Rao Sneha R.,Somarelli Jason A.,Altunel Erdem,Selmic Laura E.,Byrum Mark,Sheth Maya U.,Cheng Serene,Ware Kathryn E.,Kim So Young,Prinz Joseph A.,Devos Nicolas,Corcoran David L.,Moseley Arthur,Soderblom Erik,Hsu S. David,Eward William C.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference57 articles.

1. The price of innovation: new estimates of drug development costs;DiMasi;J Health Econ,2003

2. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program;Mirabello;Cancer,2009

3. HowladerN NooneAM KrapchoM MillerD BrestA YuM Bethesda, MDNational Cancer InstituteSEER Cancer Statistics Review, 1975-20162019

4. Microenvironmental regulation of tumor progression and metastasis;Quail;Nat Med,2013

5. Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases;Blomme;Oncogene,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiome in cancer: A comparative analysis between humans and dogs;The Veterinary Journal;2024-06

2. A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer;Frontiers in Molecular Biosciences;2023-05-09

3. Testing for Phylogenetic Signal in Single-Cell RNA-Seq Data;Journal of Computational Biology;2023-04-01

4. Psymberin, a marine-derived natural product, induces cancer cell growth arrest and protein translation inhibition;Frontiers in Medicine;2022-12-20

5. Improving Osteosarcoma Treatment: Comparative Oncology in Action;Life;2022-12-14